MannKind's Inhaled Insulin One Step Away From Approval...

April 2, 2014 10:27 AM

14
0

MannKind Corp.'s (MNKD: Quote) inhaled insulin, Afrezza, has cleared the penultimate regulatory hurdle in the U.S., following the FDA Advisory Committee's endorsement on Tuesday, and now awaits the big decision of final approval.